AngioScore completes its $12mm Series F round
AngioScore Inc. (endovascular devices) has raised $12mm through what is believed to be its Series F venture round. New institutional investor Saints Capital led (and contributes a board member) and was joined by current backers, including Psilos Group Managers, Telegraph Hill Partners, QuestMark Partners, Pelion Venture Partners, California Technology Ventures, and Innomed Ventures, as well as 15 other undisclosed investors. Funds will be used to continue developing a 100mm AngioSculpt scoring balloon catheter for peripheral artery disease, a drug-coated AngioSculpt scoring balloon catheter, and an AngioSculpt scoring balloon for valvuloplasty and use in transaortic valve implantation procedures.
- Medical Devices
- Implantable Devices
Surgical Equipment & Devices
- Minimally or Less Invasive
- Venture Financing
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com